A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy
A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy
About this item
Full title
Author / Creator
Publisher
Germany: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Germany: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Background
This study aims to evaluate the effect of subcutaneous (SC) elamipretide dosing on exercise performance using the 6 min walk test (6MWT), patient‐reported outcomes measuring fatigue, functional assessments, and safety to guide the development of the Phase 3 trial.
Methods
MMPOWER‐2 was a randomized, double‐blind, placebo‐control...
Alternative Titles
Full title
A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4e3c7d9d0ebc4d80bc122ad1421fdd2d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4e3c7d9d0ebc4d80bc122ad1421fdd2d
Other Identifiers
ISSN
2190-5991,2190-6009
E-ISSN
2190-6009
DOI
10.1002/jcsm.12559
